Cue Biopharma Inc.

NASDAQ: CUE · Real-Time Price · USD
0.80
0.01 (1.27%)
At close: Aug 15, 2025, 12:41 PM

Cue Biopharma Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
9.29M 5.49M 1.25M 14.94M
Cost of Revenue
2.35M 38.1M 1.81M -1.78M
Gross Profit
9.29M -32.61M -560.83K 16.72M
Operating Income
-41.5M -52.15M -53.22M -43.71M
Interest Income
1.62M 2.66M 928.24K 45.9K
Pretax Income
-40.67M -50.73M -53.01M -43.67M
Net Income
-40.67M -50.73M -52.8M -44.16M
Selling & General & Admin
14.59M 16.68M 16.17M 17.31M
Research & Development
36.3M 40.8M 38.58M 41.35M
Other Expenses
-93K -37.94M -35.57M 1.78M
Operating Expenses
50.79M 19.54M 19.18M 60.43M
Interest Expense
796K 1.25M 713.82K n/a
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
50.79M 57.64M 54.47M 58.65M
Income Tax Expense
n/a n/a -214.43K 495K
Shares Outstanding (Basic)
56.33M 45.75M 35.65M 31.29M
Shares Outstanding (Diluted)
56.33M 45.75M 35.65M 31.29M
EPS (Basic)
-0.72 -1.11 -1.49 -1.41
EPS (Diluted)
-0.72 -1.11 -1.49 -1.41
EBITDA
-37.53M -46.05M -50.49M -45.44M
EBIT
-39.88M -49.49M -52.3M -43.67M
Depreciation & Amortization
2.35M 3.44M 1.81M -1.78M